MTDH and neoplasm: In 50.7% of NSCLC patients, AEG-1 showed high expression (p = 0.004) having positive correlation with clinical stage (r = 0.164, p = 0.002), lymph node metastasis (r = 0.232, p < 0.001) and tumor size (r = 0.240, p < 0.001) [41].